Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal JURNAL FARMASIMED (JFM) Journal of Health Economic and Policy Research (JHEPR)
Erlisa Irawati Putri
Universitas Gadjah Mada
Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Comparative Analysis of Drug Policy Prices and National Procurement Systems in Universal Health Coverage Erlisa Irawati Putri; Chairun Wiedyaningsih; Roshinta Andien Damayanti
Journal of Health Economic and Policy Research (JHEPR) Vol. 4 No. 1 (2026): Journal of Health Economic and Policy Research
Publisher : Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30595/jhepr.v4i1.352

Abstract

Background: Access to affordable essential medicines is a key prerequisite for achieving Universal Health Coverage (UHC), particularly in developing countries facing fiscal pressures and pharmaceutical market inefficiencies. However, the effectiveness of medicine pricing policies varies significantly between countries, depending on regulatory design, procurement capacity, and political commitment to universal access. Aims: This study aims to analyse and compare drug pricing policies and national procurement systems in five Asian countries—Indonesia, the Philippines, Thailand, Malaysia, and India—in the context of UHC. Methods: This study employs a comparative policy analysis approach, utilising secondary data from national regulations, official government reports, and academic literature. Results: Thailand has demonstrated the most effective model, combining HTA, compulsory licensing, and a centralized GPO system, which reduces drug prices by up to 90%. India optimises generic procurement through the Jan Aushadhi programme, while Malaysia combines external price references with tiered enforcement policies. In contrast, Indonesia and the Philippines still face challenges in price compliance and distribution efficiency, due to institutional fragmentation and weak oversight. Conclusion: This study underscores the importance of integrating robust regulatory strategies, effective procurement mechanisms, and rigorous monitoring systems to ensure affordability and equitable access to medicines. Cross-country learning can strengthen national pharmaceutical reforms and support policy integration in the ASEAN region. Keywords: Drug prices, UHC, pharmaceutical procurement, Asian pharmaceutical policy.
Evaluation of Telemedicine Access with Health Insurance: A Systematic Review Erlisa Irawati Putri; Diah Ayu Puspandari; Anna Wahyuni Widayanti
Jurnal FARMASIMED (JFM) Vol 8 No 2 (2026): Jurnal Farmasimed (JFM)
Publisher : Fakultas Farmasi Institut Kesehatan Medistra Lubuk Pakam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35451/bne7rx24

Abstract

Introduction: Telemedicine transforms healthcare through electronic Communication technologies and offers high-quality medical treatments from a distance. The COVID-19 pandemic is accelerating the adoption of telemedicine, making its integration with insurance financing a strategic step to increase access to healthcare, reduce the financial strain on patients, and ensure continuity of service. Some nations have extended the coverage of private insurance companies and health insurance programs like Medicare and Medicaid to include telemedicine services. Objectives: Assess the impact of implementing telemedicine technology in the context of insurance financing and formulate policy recommendations to improve the accessibility and effectiveness of health services. Methods: Following PRISMA guidelines, a comprehensive search was conducted in Scopus, ScienceDirect, and PubMed, covering studies from 2015 to 2024. The inclusion criteria described telemedicine or telehealth financed by health insurance written in English. Based on the inclusion criteria, seven articles were reviewed in this article. We then assessed the studies’ quality using different research evaluation tools based on the research methods. Results: Health insurance-backed telemedicine has been shown to increase access to healthcare, lessen individuals’ financial burdens, and enhance the standard of medical care. However, several issues, including inadequate infrastructure, low digital literacy, and unclear regulations, continue to impede the use of telemedicine in conjunction with health insurance programs. Adapting to telemedicine presents challenges for elderly populations and people with physical disabilities. Policies, training for healthcare professionals, and technical advancements are required for these services to be inclusive and sustainable. Conclusion: Health insurance-backed telemedicine can improve access and efficiency of care and reduce patients’ financial burdens. By implementing corrective measures, as some countries have successfully done, health systems can maximise the benefits of telemedicine and create more inclusive, efficient, and sustainable health services.
Co-Authors Anna Wahyuni Widayanti Chairun Wiedyaningsih Roshinta Andien Damayanti